HBM HEALTHCARE INVESTMENTS LTDHBM HEALTHCARE INVESTMENTS LTDHBM HEALTHCARE INVESTMENTS LTD

HBM HEALTHCARE INVESTMENTS LTD

No trades
Buy 5H5A
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪1.33 B‬EUR
‪−1.11 M‬EUR
‪5.45 M‬
Beta (1Y)
1.04

About HBM HEALTHCARE INVESTMENTS LTD


Sector
CEO
Andreas Wicki
Headquarters
Zug
Founded
2001
ISIN
CH0012627250
FIGI
BBG000S6RFR3
As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures' portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
Performance
Revenue to profit conversion
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.